The Childhood Immunization Schedule and Safety -  Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule,  Board on Population Health and Public Health Practice,  Institute of Medicine

The Childhood Immunization Schedule and Safety

Stakeholder Concerns, Scientific Evidence, and Future Studies
Buch | Softcover
236 Seiten
2013
National Academies Press (Verlag)
978-0-309-26702-1 (ISBN)
48,60 inkl. MwSt
  • Keine Verlagsinformationen verfügbar
  • Artikel merken
Reviews scientific findings and stakeholders concerns related to the safety of the recommended childhood immunization schedule. This report identifies potential research approaches, methodologies and study designs that could inform this question, considering strengths, weaknesses as well as ethical and financial feasibility of each approach.
Vaccines are among the most safe and effective public health interventions to prevent serious disease and death. Because of the success of vaccines, most Americans today have no firsthand experience with such devastating illnesses as polio or diphtheria. Health care providers who vaccinate young children follow a schedule prepared by the U.S. Advisory Committee on Immunization Practices. Under the current schedule, children younger than six may receive as many as 24 immunizations by their second birthday. New vaccines undergo rigorous testing prior to receiving FDA approval; however, like all medicines and medical interventions, vaccines carry some risk. Driven largely by concerns about potential side effects, there has been a shift in some parents' attitudes toward the child immunization schedule. The Childhood Immunization Schedule and Safety identifies research approaches, methodologies, and study designs that could address questions about the safety of the current schedule. This report is the most comprehensive examination of the immunization schedule to date.
The IOM authoring committee uncovered no evidence of major safety concerns associated with adherence to the childhood immunization schedule. Should signals arise that there may be need for investigation, however, the report offers a framework for conducting safety research using existing or new data collection systems.

1 Front Matter; 2 Summary; 3 1 Introduction; 4 2 Determination of the Immunization Schedule; 5 3 Existing Data Sources and Systems; 6 4 Stakeholder Concerns Related to the Safety of the Immunization Schedule; 7 5 Review of Scientific Findings; 8 6 Methodological Approaches to Studying Health Outcomes Associated with the Current Immunization Schedule: Options, Feasibility, Ethical Issues, and Priorities; 9 7 Conclusions and Recommendations; 10 Appendix A: 2012 Advisory Committee on Immunization Practices' Recommended Immunization Schedule for Children; 11 Appendix B: Glossary; 12 Appendix C: Acronyms; 13 Appendix D: Study Designs for the Safety Evaluation of Different Childhood Immunization Schedules--Martin Kulldorff; 14 Appendix E: Agendas of Public Meetings Held by the Committee; 15 Appendix F: Biographical Sketches of Committee Members; 16 Appendix G: Institute of Medicine Publications on Vaccines

Verlagsort Washington
Sprache englisch
Maße 152 x 229 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pädiatrie
Studium Querschnittsbereiche Infektiologie / Immunologie
Studium Querschnittsbereiche Prävention / Gesundheitsförderung
ISBN-10 0-309-26702-1 / 0309267021
ISBN-13 978-0-309-26702-1 / 9780309267021
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Oliver Schmetzer

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00
Antibiotika, Virostatika, Antimykotika, Antiparasitäre Wirkstoffe

von Hans-Reinhard Brodt; Achim Hörauf; Michael Kresken …

Buch (2024)
Thieme (Verlag)
165,00